KEGG: bqu:BQ06840
STRING: 283165.BQ06840
Glutamate--tRNA ligase 2 (gltX2) in B. quintana is an essential enzyme responsible for catalyzing the attachment of glutamate to its cognate tRNA (tRNA^Glu), a critical step in protein biosynthesis. Unlike many bacteria that possess a single gltX gene, B. quintana contains two distinct glutamyl-tRNA synthetase genes (gltX1 and gltX2), suggesting specialized functions. The gltX2 enzyme likely plays a crucial role in B. quintana's adaptation to different environments during its infectious cycle, particularly when transitioning between the hemin-restricted human bloodstream (37°C) and the hemin-rich body louse vector environment (28°C) . This adaptation is essential as B. quintana must survive in these dramatically different niches to maintain its transmission cycle.
For optimal expression of recombinant B. quintana gltX2, researchers should consider a strategy similar to that used for other B. quintana proteins :
Vector selection: pET-28a(+) vector system with an N-terminal 6×His tag has been successfully used for B. quintana proteins and would likely be appropriate for gltX2 .
Expression system: E. coli BL21(DE3) is recommended due to its reduced protease activity and compatibility with T7 promoter-based expression.
Culture conditions:
Initial growth at 37°C to OD600 of 0.6-0.8
Induction with 0.5-1.0 mM IPTG
Post-induction temperature reduction to 18-25°C for 16-20 hours to enhance protein solubility
Buffer optimization:
Lysis buffer: 50 mM Tris-HCl pH 8.0, 300 mM NaCl, 10% glycerol, 1 mM DTT, and protease inhibitors
Addition of 0.1-0.5% Triton X-100 can improve solubility
Purification protocol:
Immobilized metal affinity chromatography using Ni-NTA resin
Size exclusion chromatography for higher purity
This methodology is based on successful expression strategies for other B. quintana proteins and standard approaches for aminoacyl-tRNA synthetases from related organisms.
B. quintana has a unique ability to survive exposure to hemin concentrations that are typically bactericidal (>1 mM) . This adaptation is critical for survival in the hemin-rich body louse environment compared to the hemin-restricted human bloodstream. To investigate how hemin concentration affects gltX2:
Expression analysis: Culture B. quintana under varying hemin concentrations (0.1 mM to 2.0 mM) and quantify gltX2 expression using RT-qPCR . Compare this with expression patterns of known hemin-responsive genes like rpoE, which shows upregulation under high hemin conditions.
Enzyme activity assays: Measure the aminoacylation activity of purified recombinant gltX2 in the presence of different hemin concentrations using:
ATP-PPi exchange assay
tRNA aminoacylation assay with [³H]-glutamate
Analysis of reaction kinetics (Km and Vmax) to determine if hemin acts as an activator or inhibitor
Structural analysis: Investigate potential hemin-binding sites in gltX2 through:
UV-visible spectroscopy to detect hemin-protein interactions
Site-directed mutagenesis of potential hemin-binding residues
Crystallography of gltX2 with and without hemin
This comprehensive approach would elucidate whether gltX2 plays a role in B. quintana's remarkable tolerance to high hemin concentrations, which is a key adaptation for survival in the body louse vector .
B. quintana employs various stress response mechanisms to survive environmental transitions. The extracytoplasmic function (ECF) sigma factor RpoE has been identified as important in mediating B. quintana's tolerance to high hemin concentrations and temperature changes . To investigate potential relationships between gltX2 and stress response pathways:
Transcriptional regulation analysis:
Perform chromatin immunoprecipitation sequencing (ChIP-seq) with antibodies against RpoE to determine if gltX2 is part of the RpoE regulon
Analyze the gltX2 promoter region for ECF15 sigma factor binding motifs
Construct reporter gene fusions to measure gltX2 promoter activity in response to various stressors
Protein-protein interaction studies:
Use bacterial two-hybrid assays to detect interactions between gltX2 and stress response proteins
Perform co-immunoprecipitation experiments followed by mass spectrometry to identify protein complexes
Investigate if NepR (anti-sigma factor) or PhyR (response regulator) influence gltX2 expression or activity
Mutant phenotype analysis:
This research would provide insight into whether gltX2 functions beyond protein synthesis as part of B. quintana's adaptive stress response network.
Designing experiments to assess gltX2 function during B. quintana's complex infection cycle requires approaches that span in vitro, in vivo, and ex vivo systems:
In vitro host-vector models:
Develop a temperature-shift model (37°C to 28°C) with varying hemin concentrations to mimic transition between host and vector
Monitor gltX2 expression and protein levels during transitions
Use conditional expression systems to modulate gltX2 levels at different stages
Ex vivo infection models:
Establish body louse gut epithelial cell cultures and human erythrocyte/endothelial cell co-cultures
Assess gltX2 expression in bacteria attached to or internalized within different cell types
Compare wild-type bacteria with gltX2 mutants for attachment, invasion, and persistence
In vivo approaches:
Develop body louse infection models to study gltX2 expression and bacterial fitness in the vector
Consider humanized mouse models for studying mammalian infection aspects
Use competition assays between wild-type and gltX2 mutants to assess fitness costs
Multi-omics integration:
Combine transcriptomics, proteomics, and metabolomics data to build a systems-level understanding of gltX2 function
Use stable isotope labeling to track glutamate incorporation during different infection stages
This experimental framework would provide comprehensive insights into gltX2 function throughout the B. quintana lifecycle and potentially identify novel therapeutic targets.
Purifying active recombinant B. quintana gltX2 requires specific techniques to maintain enzyme functionality:
Expression optimization:
Test multiple fusion tags beyond 6×His, including MBP (maltose binding protein) which has been successful for other B. quintana proteins
Use specialized E. coli strains like Rosetta or Arctic Express to address potential codon bias or folding issues
Co-express with bacterial chaperones (GroEL/GroES) if solubility is problematic
Purification protocol:
| Step | Method | Buffer Composition | Notes |
|---|---|---|---|
| Lysis | Sonication or French press | 50 mM Tris-HCl pH 7.5, 300 mM NaCl, 10% glycerol, 5 mM β-mercaptoethanol | Add 0.1% Triton X-100 for membrane dissociation |
| IMAC | Ni-NTA affinity | Above + 20-250 mM imidazole gradient | Low imidazole wash (20 mM) followed by elution |
| Ion exchange | Q-Sepharose | 50 mM Tris-HCl pH 7.5, 50-500 mM NaCl gradient | Removes nucleic acid contaminants |
| Size exclusion | Superdex 200 | 20 mM HEPES pH 7.5, 150 mM NaCl, 5% glycerol, 1 mM DTT | Ensures homogeneity |
Activity preservation:
Include 5-10% glycerol in all buffers to maintain stability
Add zinc or magnesium ions (1-5 mM) as cofactors
Store purified protein at -80°C in single-use aliquots with 20% glycerol
Quality assessment:
Circular dichroism to confirm proper folding
Dynamic light scattering to verify monodispersity
Aminoacylation activity assays to confirm function
This comprehensive purification strategy accounts for the challenges often encountered with B. quintana proteins and should yield active recombinant gltX2 suitable for structural and functional studies.
Developing specific inhibitors for B. quintana gltX2 involves a structured drug discovery approach focusing on selectivity over human glutamyl-tRNA synthetase:
Structural analysis and target validation:
Solve the crystal structure of B. quintana gltX2
Perform structural alignment with human glutamyl-tRNA synthetase
Identify unique binding pockets or conformational states
Validate gltX2 as an essential target using conditional knockdown systems
Inhibitor discovery strategies:
Structure-based virtual screening against identified binding pockets
Fragment-based screening using thermal shift assays
Repurposing known aminoacyl-tRNA synthetase inhibitors
High-throughput biochemical assays using the ATP-PPi exchange reaction
Compound optimization workflow:
| Stage | Methods | Endpoints | Success Criteria |
|---|---|---|---|
| Primary screening | Biochemical assays | IC50 for enzyme inhibition | <10 μM potency |
| Selectivity | Parallel testing against human enzyme | Selectivity index | >100-fold selectivity |
| Cellular activity | B. quintana growth inhibition | MIC determination | MIC <5 μg/ml |
| Mechanism validation | Enzyme kinetics, binding studies | Ki, binding mode | Confirmed mechanism |
| Lead optimization | Medicinal chemistry, ADME studies | Improved properties | Suitable for in vivo testing |
In vitro and ex vivo efficacy assessment:
Test in B. quintana cultures at both 28°C and 37°C conditions
Evaluate efficacy in cell infection models
Assess activity against intracellular bacteria
Determine effect on bacterial persistence and stress tolerance
This systematic approach leverages structural and functional information about gltX2 to develop selective inhibitors that could serve as research tools or potential therapeutic leads for B. quintana infections.
Investigating gltX2's role in B. quintana pathogenesis requires integrating molecular and cellular approaches:
Genetic manipulation strategies:
Conditional gene expression systems using tetracycline-inducible promoters
CRISPR interference (CRISPRi) for partial knockdown if complete deletion is lethal
Site-directed mutagenesis of catalytic residues to create enzymatically inactive variants
Complementation with wild-type or mutant alleles to verify phenotypes
Host-pathogen interaction models:
Virulence assessment methodologies:
Clinical relevance evaluation:
For patients with confirmed B. quintana infection and varied clinical presentations (trench fever, endocarditis, bacillary angiomatosis) , analyze:
| Clinical Presentation | Samples to Analyze | Parameters to Measure | Expected Findings |
|---|---|---|---|
| Bacteremia | Blood | gltX2 expression levels | Potential correlation with persistence |
| Endocarditis | Valve tissue | gltX2 protein localization | Association with vegetation formation |
| Neurological symptoms | CSF | Antibody response to gltX2 | Potential diagnostic marker |
This comprehensive approach would provide insights into whether gltX2 functions as a direct virulence factor or if its role is primarily metabolic but indirectly impacts pathogenicity through bacterial fitness and persistence .
Comparative analysis of gltX2 across Bartonella species provides evolutionary insights and reveals potential species-specific adaptations:
Phylogenetic analysis approach:
Construct multiple sequence alignments of gltX2 from B. quintana, B. henselae, B. vinsonii, and other Bartonella species
Calculate sequence conservation and identify species-specific variations
Map variations onto structural models to predict functional consequences
Trace evolutionary history of gltX duplication events in the Bartonella lineage
Functional comparison methodology:
Express and purify recombinant gltX2 from multiple Bartonella species
Compare enzymatic parameters (kcat, Km) for glutamate and tRNA substrates
Assess temperature optima and stability profiles in relation to host body temperatures
Evaluate response to environmental stressors relevant to each species' lifecycle
Host-specificity correlation:
This comparative approach would determine whether differences in gltX2 contribute to the distinct host preferences, transmission vectors, and disease manifestations observed across Bartonella species.
Recent research on aminoacyl-tRNA synthetases has revealed numerous functions beyond their classical role in protein synthesis. To investigate potential non-canonical functions of B. quintana gltX2:
Protein interaction network analysis:
Perform pull-down assays with tagged gltX2 followed by mass spectrometry
Use bacterial two-hybrid screens to identify interaction partners
Map the interaction network and identify connections to signaling pathways
Regulatory RNA studies:
Investigate whether gltX2 binds non-cognate RNAs using RNA immunoprecipitation
Perform CLIP-seq (cross-linking immunoprecipitation-sequencing) to identify all RNA targets
Assess potential moonlighting functions in regulating gene expression
Alternative substrate screening:
Host-pathogen interface functions:
Assess if gltX2 or fragments are secreted during infection
Test for potential immunomodulatory effects on host cells
Investigate if host glutamyl-tRNA synthetase function is affected during infection
This research direction would expand our understanding of gltX2 beyond its canonical role and potentially reveal new therapeutic targets if moonlighting functions contribute to pathogenesis.
Advanced structural biology approaches offer unprecedented opportunities to understand gltX2 function and dynamics:
Cryo-electron microscopy applications:
Achieve high-resolution structures of gltX2 in different functional states
Visualize gltX2-tRNA complexes to understand recognition mechanisms
Capture conformational changes during catalysis
Examine potential oligomeric states or interaction with other cellular components
Integrative structural biology approach:
Combine X-ray crystallography, NMR, and SAXS data
Use hydrogen-deuterium exchange mass spectrometry to map conformational dynamics
Apply molecular dynamics simulations to predict functional motions
Employ cross-linking mass spectrometry to validate protein interaction networks
In situ structural studies:
Use cryo-electron tomography to visualize gltX2 localization within bacterial cells
Apply proximity labeling techniques to map the spatial organization
Implement super-resolution microscopy to track gltX2 during different growth conditions
These advanced structural approaches would provide unprecedented insights into how gltX2 functions in the context of B. quintana's adaptation to its unique lifecycle between human hosts and louse vectors , potentially revealing structural features that could be exploited for targeted drug development.
Comprehensive bioinformatic analysis of gltX2 in the broader metabolic context of B. quintana requires integrative approaches:
Metabolic network reconstruction:
Comparative genomics methodology:
Analyze the genomic context of gltX2 across Bartonella species
Identify conserved operon structures or regulatory elements
Perform synteny analysis to detect genomic rearrangements affecting gltX2
Compare with related alphaproteobacteria to identify unique features
Regulatory network inference:
Multi-omics data integration framework:
| Data Type | Analysis Approach | Integration Method | Expected Insights |
|---|---|---|---|
| Genomics | SNP/variation analysis | Mapping to structure | Potential adaptive mutations |
| Transcriptomics | Differential expression | Co-expression networks | Condition-specific regulation |
| Proteomics | Protein abundance | Correlation analysis | Post-transcriptional control |
| Metabolomics | Glutamate/glutamine flux | Pathway analysis | Metabolic consequences |
This systems biology approach would position gltX2 within the broader context of B. quintana metabolism and adaptation to different host environments.
Researchers face several technical challenges when studying B. quintana gltX2:
Cultivation difficulties:
Challenge: B. quintana is fastidious, requiring specialized media and extended incubation periods (12-14 days for primary isolation)
Solution: Use liquid BAPGM (Bartonella alpha-Proteobacteria growth medium) enrichment cultures prior to plating on solid media , optimize hemin concentration based on experimental goals , and implement co-cultivation with eukaryotic cells for enhanced recovery
Genetic manipulation limitations:
Challenge: Low transformation efficiency and limited genetic tools for B. quintana
Solution: Adapt techniques from related alphaproteobacteria, optimize electroporation conditions specific to B. quintana, and develop shuttle vectors with appropriate selection markers
Protein expression and purification hurdles:
In vivo model constraints:
Challenge: Limited animal models that recapitulate B. quintana's natural infection cycle
Solution: Develop humanized mouse models, establish body louse colonies for vector studies, and create ex vivo systems mimicking human vascular endothelium
Functional redundancy complications:
Challenge: Potential functional overlap between gltX1 and gltX2 complicating phenotypic analysis
Solution: Develop conditional expression systems, use CRISPRi for partial knockdowns, and employ isoform-specific inhibitors
By addressing these technical challenges with innovative approaches, researchers can overcome the difficulties inherent to studying this fastidious pathogen and its aminoacyl-tRNA synthetases.
Research on B. quintana gltX2 has broader implications for understanding vector-borne pathogen biology:
Comparative adaptation mechanisms:
Insights from how gltX2 functions in the host-vector transition of B. quintana can inform studies of adaptation in other vector-borne pathogens like Rickettsia, Borrelia, and Anaplasma
The temperature-responsive regulation mechanisms may represent conserved strategies across arthropod-transmitted bacteria
Vector colonization strategies:
Understanding how translation machinery components like gltX2 adapt to the vector environment can reveal common mechanisms for vector colonization
These insights could lead to novel strategies for blocking transmission at the vector stage
Co-infection dynamics:
Translational significance:
Aminoacyl-tRNA synthetases represent promising broad-spectrum antibiotic targets
Insights from B. quintana gltX2 could inform drug development strategies applicable to multiple vector-borne pathogens
Understanding vector-specific adaptations could lead to transmission-blocking interventions
This research field thus serves as a model for studying fundamental aspects of vector-pathogen-host interactions applicable across multiple disease systems.